Reduced-Dose Melphalan vs. Standard Dose Melphalan for Autologous Stem Cell Transplantation: Is There a Difference in Outcome?

Abstract

other management strategies. Associated increases in MAP, weight, and serum creatinine at the time of PRES compared to baseline measurements exemplify the importance of possible prevention through more aggressive blood pressure and fluid management strategies in this patient population.